Asbestos-Linked Cancer Attacked With New Drug Targets
This article is for subscribers only.
Heather Von St. James, 45, remembers her father, a demolition worker, coming home covered in dust and dirt. Still, she’d hug him each night and, sometimes, put on his coat and shoes to play.
Thirty years later, she paid a price. At age 36, with a 3-month-old daughter, Von St. James was diagnosed with mesothelioma, a deadly, incurable cancer tied to asbestos exposure that can take decades to develop and often kills within months after symptoms appear. She was told her only chance to live was to have a lung removed.